New Search

Refine your search within these categories:

1. Human Genes (group results)

2. Interaction: Human Genes and Chemicals (group results)

3. Bioactivity

4. Semantic Terms (group results)

A. Anatomy (group results)

B. Organisms (group results)

C01. Bacterial Infections and Mycoses (group results)

C02. Virus Diseases (group results)

C03. Parasitic Diseases (group results)

C04. Neoplasms (group results)

C05. Musculoskeletal Diseases (group results)

C06. Digestive System Diseases (group results)

C07. Stomatognathic Diseases (group results)

C08. Respiratory Tract Diseases (group results)

C09. Otorhinolaryngologic Diseases (group results)

C10. Nervous System Diseases (group results)

C11. Eye Diseases (group results)

C12. Male Urogenital Diseases (group results)

C13. Female Urogenital Diseases and Pregnancy Complications (group results)

C14. Cardiovascular Diseases (group results)

C15. Hemic and Lymphatic Diseases (group results)

C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results)

C17. Skin and Connective Tissue Diseases (group results)

C18. Nutritional and Metabolic Diseases (group results)

C19. Endocrine System Diseases (group results)

C20. Immune System Diseases (group results)

C21. Disorders of Environmental Origin (group results)

C22. Animal Diseases (group results)

C23. Pathological Conditions, Signs and Symptoms: all > Pathologic Processes [MESH:D010335] > Metaplasia [MESH:D008679] > Neovascularization, Pathologic [MESH:D009389] > Choroidal Neovascularization [MESH:D020256]

C24. Occupational Diseases (group results)

C25. Chemically-Induced Disorders (group results)

C26. Wounds and Injuries (group results)

D01. Inorganic Chemicals (group results)

D02. Organic Chemicals (group results)

D03. Heterocyclic Compounds (group results)

D04. Polycyclic Compounds (group results)

D05. Macromolecular Substances (group results)

D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results)

D08. Enzymes and Coenzymes (group results)

D09. Carbohydrates (group results)

D10. Lipids (group results)

D12. Amino Acids, Peptides, and Proteins (group results)

D13. Nucleic Acids, Nucleotides, and Nucleosides (group results)

D20. Complex Mixtures (group results)

D23. Biological Factors (group results)

D25. Biomedical and Dental Materials (group results)

D26. Pharmaceutical Preparations (group results)

D27. Chemical Actions and Uses (group results)

E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results)

F. Psychiatry and Psychology (group results)

G. Phenomena and Processes (group results)

I. Anthropology, Education, Sociology and Social Phenomena

J. Technology, Industry, Agriculture (group results)

N. Health Care

Recently Viewed Items
 
These terms define your current search. Click the
×
to remove a term.

C23. Pathological Conditions, Signs and Symptoms: Pathologic Processes [MESH:D010335] > Metaplasia [MESH:D008679] > Neovascularization, Pathologic [MESH:D009389] > Choroidal Neovascularization [MESH:D020256]
×

Items 161 to 200 of 550 results
Group by: C23. Pathological Conditions, Signs and Symptoms
Sort by: MeSH_UID, MeSH_NAME
 
1
41
81
121
161
201
241
281
321
361
401
...
521
MESH:C081643
 candesartan
C081643
 
  
  
  
MESH:C082486
 13-hydroxy-10-oxo-11-octadecenoic acid
C082486
 
  
  
  
MESH:C084178
 telmisartan
C084178
 
  
  
  
MESH:C085746
 rottlerin
C085746
 
  
  
  
MESH:C085911
 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
C085911
 
  
  
  
MESH:C088115
 anacardic acid
C088115
 
  
  
  
MESH:C088327
 JM 3100
C088327
 
  
  
  
MESH:C088658
 zoledronic acid
C088658
 
  
  
  
MESH:C089032
 rimonabant
C089032
 
  
  
  
MESH:C089730
 rosiglitazone
C089730
 
  
  
  
MESH:C090937
 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
C090937
 
  
  
  
MESH:C090942
 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole
C090942
 
  
  
  
MESH:C091768
 3'-methoxy-4'-nitroflavone
C091768
 
  
  
  
MESH:C093642
 SB 203580
C093642
 
  
  
  
MESH:C093973
 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
C093973
 
  
  
  
MESH:C095105
 bexarotene
C095105
 
  
  
  
MESH:C097613
 imatinib
C097613
 
  
  
  
MESH:C098657
 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c )pyrimidine
C098657
 
  
  
  
MESH:C100122
 meclocycline
C100122
 
  
  
  
MESH:C101044
 tyrphostin AG 1478
C101044
 
  
  
  
MESH:C101426
 sildenafil
C101426
 
  
  
  
MESH:C102148
 nitroaspirin
C102148
 
  
  
  
MESH:C103303
 alitretinoin
C103303
 
  
  
  
MESH:C104810
 methyl arachidonylfluorophosphonate
C104810
 
  
  
  
MESH:C105260
 4-tert-octylphenol
C105260
 
  
  
  
MESH:C105832
 aurapten
C105832
 
  
  
  
MESH:C105934
 celecoxib
C105934
 
  
  
  
MESH:C106335
 macrophage stimulatory lipopeptide 2
C106335
 
  
  
  
MESH:C107676
 deguelin
C107676
 
  
  
  
MESH:C109986
 2-aminoethoxydiphenyl borate
C109986
 
  
  
  
MESH:C110630
 SR 144528
C110630
 
  
  
  
MESH:C110904
 capecitabine
C110904
 
  
  
  
MESH:C111237
 vorinostat
C111237
 
  
  
  
MESH:C113580
 U 0126
C113580
 
  
  
  
MESH:C113831
 poly-N-acetyl glucosamine
C113831
 
  
  
  
MESH:C115612
 single bond
C115612
 
  
  
  
MESH:C116890
 Semaxinib
C116890
 
  
  
  
MESH:C118739
 entinostat
C118739
 
  
  
  
MESH:C120099
 GW 1929
C120099
 
  
  
  
MESH:C120158
 phosphomannopentaose sulfate
C120158
 
  
  
  
1
41
81
121
161
201
241
281
321
361
401
...
521